BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 6415193)

  • 1. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.
    Koutts J; Walsh PN; Plow EF; Fenton JW; Bouma BN; Zimmerman TS
    J Clin Invest; 1978 Dec; 62(6):1255-63. PubMed ID: 311783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
    Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
    Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental diabetes and platelet aggregation in the rat.
    Murray J; Kaneko JJ; Rucker RB
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen.
    Zucker MB; Broekman MJ; Kaplan KL
    J Lab Clin Med; 1979 Nov; 94(5):675-82. PubMed ID: 501196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor VIII complex activities in acute leukemia].
    Pniejnia-OlszyƄski W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
    Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
    J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases.
    Ruggeri ZM; Ciavarella N; Mannucci PM; Molinari A; Dammacco F; Lavergne JM; Meyer D
    J Lab Clin Med; 1979 Jul; 94(1):60-75. PubMed ID: 112210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man.
    Bensoussan D; Levy-Toledano S; Passa P; Caen J; Canivet J
    Diabete Metab; 1977 Dec; 3(4):223-7. PubMed ID: 304425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced platelet-mediated and enhanced leukocyte-mediated fibrinolysis in experimentally induced diabetes in rats.
    Winocour PD; Colwell JA
    J Lab Clin Med; 1985 May; 105(5):613-8. PubMed ID: 3989354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.